Pleural Cholesterol to the Diagnosis of Exudative Effusion

INTRODUCTION

A pleural effusion (PE) is a frequent challenge in medical practice. A PE is an abnormal collection of fluid between the parietal and visceral pleurae. The following pathological mechanisms have been isolated or isolated in association, which are correlated with the development of a PE: a thoracic duct obstruction, a pleural permeability increase, a capillary pulmonary pressure increase, low oncotic pressure and low intrapleural pressure [1,2]. In such cases, pleural disease is present and is typically unilateral. A specific approach is needed to diagnose pleural disease, which is particularly important for infectious and neoplastic disease. Most PEs are a manifestation of a dysfunction or a distant clinical disease, such as hepatic, cardiac or renal failure. A PE diagnosis is established based on anamnesis and a physical exam, together with an imaging method that shows the pleural fluid collection [1,2]. Parameters, such as patient symptoms, clinical past diagnoses, and effusion volume, are essential in the medical decision to perform thoracentesis, which will categorize the effusion as a transudate or an exudate and help identify the etiology of the effusion [1-3].

Since 1972, a diagnosis of an exudative pleural effusion has been established when the fluid characteristics meet one of Light’s criteria, which include a pleural/serum proteinratio (PP/SP) > 0.5, a pleural/serum LDH level > 0.6 and a pleural LDH level over 2/3 of the reference value (or 200 IU) [4]. Few alternative biomarkers have been proposed to determine an exudative PE. Pleural cholesterol (PC) and the pleural/serum cholesterol ratio (PC/SC) have been found in the literature as alternative biomarkers to Light’s criteria but without consistent data [5-7].

OBJECTIVES

General: To study PC and the PC/SC ratio as markers of an exudative pleural effusion.

Specific: To determine the specificity, sensitivity, and predictive values of pleural cholesterol in the diagnosis of exudative pleural effusions.

MATERIALS AND METHODS

This study was a case series of 100 consecutive patients with pleural effusions who attended the pleural disease center of a university hospital from March 2009 to March 2012.

RESULTS

Of 100 patients who were screened, 79 met the inclusion criteria and were definitively diagnosed with an exudative pleural effusion when the effusion was analyzed based on Light’s criteria. There were 34 females (43%) and 45 males

(57%). The median age was 54 years (range = 18-84 years). Overall, 48 patients were diagnosed with tuberculosis (61%), 25 patients with cancer (32%), 2 patients with empyema (3%), 1 patient with chylothorax (1%), 1 patient with amyloidosis (1%), 1 patient with a pancreatic pleural effusion (1%) and 1 patient with non-tuberculosis mycobacteriosis (1%) (Table 1). The mean pleural cholesterol level in the exudates was 90.39 mg/dL. Overall, 18 patients had a serum cholesterol level ≥ 200 mg/dL. When each parameter was individually compared to Light’s criteria, the following percent errors occurred in the diagnosis of the exudates: 5.97% for the LDH ratio, 7.04% for the protein ratio, 2.7% for PC, and 18.51% for the cholesterol ratio. PC had a sensitivity of 97.22%, a specificity of 85.71%, a positive predictive value of 98.59% and a negative predictive value of 75%. The PC/SC ratio indicated a sensitivity of 81.48%, a specificity of 57.14%, a positive predictive value of 93.61% and a negative predictive value of 28.57% (Table 2).

The cut-off for the diagnosis of the exudates using PC and the PC/SC ratio was determined (Table 3). Using Light’s criteria (the LDH ratio) as a reference and the PC values, an ROC curve was generated (Fig. 1). In an ROC curve, the true positive rate (sensitivity) is plotted as a function of the false-positive rate (specificity) for different cut-off points. Each point on the ROC curve represents a sensitivity/specificity pair that corresponds to a particular decision threshold. A test with perfect discrimination (no overlap between the two distributions) has an ROC curve that passes through the upper left corner (100% sensitivity and 100% specificity). The bias using the Bland-Altman plot was as follows: for PC/SC and pLDH/sLDH, 1.93 (SD 5.24), with limits of agreement (LA) from -8.36 to 12.19; for PC/SC and PP/SP, 0.11 (SD 0.17), with LA from -0.23 to 0.46; for PC and pLDH, -1097 (SD 4138), with LA from -9207 to 7012 (Fig. 2).

DISCUSSION

Since 1881, physicians have proposed that an etiological diagnosis of a pleural effusion can be made by thoracentesis and that the characterization of the effusion is essential to therapeutic decision making. In addition, the importance of the pleural protein level (1931) and the LDH level (1957) has been recognized. In 1972, Light et al. published a study in which exudative effusions could be distinguished from transudative effusions using both parameters with a high sensitivity and an acceptable specificity [4].

The sensitivity of Light’s criteria is approximately 100% for exudates. However, up to 30% of transudates are misclassified as exudates according to these criteria. This misclassification has severe consequences for the patient and can lead to additional diagnostic approaches, such as subsequent thoracentesis with biopsy, surgery, or thoracoscopy [8-11]. False exudative effusions are associated with previous diuretic use, which alters serum and pleural biochemistry, including the cholesterol concentration. In addition, a high number of thoracentesis procedures leads to an increase in pleural LDH and contributes to a false exudative diagnosis.

Other parameters that have been studied as possible alternatives to Light’s criteria include the serum-pleural albumin gradient and the NT-ProBNP [12].

A precise and fast analysis is necessary to treat patients with pleural effusions. Exudative effusions were correctly identified in this study. Light’s criteria are superior to pleural cholesterol despite the high sensitivity and positive predictive value of both cholesterol parameters. The specificity of pleural cholesterol was lower than that in previous studies [13-16]. The use of a single pleural biochemical marker to diagnose a pleural effusion is important because additional tests may not be needed, which would improve the benefit/cost ratio. However, the pleural LDH and protein values can be used as prognostic markers in pleurodesis surgery for patients with a chronic symptomatic pleural effusion [2,8]. PC has not been evaluated for these patients. In this study, there were 13 patients with hypercholesterolemia. In these cases, the PC/SC ratio can be used to offset the PC higher values.

CONCLUSION

The pleural cholesterol level can be used as an independent variable to diagnose an exudative effusion and can replace Light’s criteria.

REFERENCES